Late-onset Familial Segmental Dystonia with Novel GNAL Mutation
Objective: Report a unique onset of dystonia in family affected by tremor and segmental dystonia Background: Background: A 66-year-old woman of Norweigan descent presented with…GPi-DBS for KMT2B-associated dystonia: systematic review and meta-analysis
Objective: To determine the efficacy of pallidal stimulation and GPi-DBS in KMT2B-associated dystonia. Background: Early evidence suggests good response to pallidal stimulation in KMT2B dystonia,…Evaluation of abnormal cerebellar iron distribution in idiopathic cervical dystonia using quantitative susceptibility mapping
Objective: This study aimed to investigate abnormal cerebellar iron distribution in patients with idiopathic CD using quantitative susceptibility mapping (QSM). Background: Idiopathic CD is a…Overview of the population of patients with advanced Parkinson’s disease (aPD) initiating therapy with levodopa-carbidopa intestinal gel (LCIG): POMPE-PARK study on French health insurance data (2013-2017)
Objective: To quantify the number of French aPD patients initiating continuous delivery of LCIG from 2013 to 2017 and to describe their demographic, clinical and…Is past use of statins associated with lower incidence of Parkinson’s disease?
Objective: To examine the relation of past exposure to statins with Parkinson’s disease (PD) incidence. Background: Drug repurposing has recently emerged as a promising approach…Virtual Rehabilitation for Functional Movement Disorder
Objective: We describe initial experiences using virtual rehabilitation in a specialized outpatient functional movement disorder (FMD) clinic. Background: Specialized rehabilitation programs have been shown to…HSP-SPG5A/CYP7B1: unusual clinical and genetic characteristics in an Indian family
Objective: To carry out a clinical and genetic study of a large Indian family emigrated in Italy with autosomal dominant hereditary spastic paraplegia (ADHSP). Background:…Proof-of-concept study testing bevantolol (SOM3355) as treatment of chorea in Huntington’s disease
Objective: Proof-of-concept phase IIa study assessing bevantolol (SOM3355) efficacy and safety in reducing chorea in Huntington’s disease (HD). Background: Bevantolol hydrochloride, a β1‐adrenoceptor antagonist used…The Huntington’s Disease Structured Interview of Function (HD-SIF): A remotely administered caregiver interview for later stage HD
Objective: To create structured interviews for the UHDRS ’99 functional scales that can be remotely administered to caregivers of Huntington’s disease gene expansion carriers (HDGECs)…Lance-Adams Syndrome: A case series in El Salvador
Objective: To describe the clinical presentation and response to treatment of cases of Lance-Adams Syndrome in a Movement Disorders Clinic in El Salvador. Background: Lance-Adams…
- « Previous Page
- 1
- …
- 115
- 116
- 117
- 118
- 119
- …
- 132
- Next Page »